FDAnews
www.fdanews.com/articles/158882-the-press-release-conviction-of-a-biotech-ceo-and-its-impact-on-scientific-research

The Press-Release Conviction of a Biotech CEO and Its Impact on Scientific Research

September 24, 2013
Some scientists are worried that the six-month house arrest convinction of W. Scott Harkonen for statements that the FDA called misleading over results of a Phase III study of Actimmune will set a precedent for other pharmaceutical scientists attempting to extrapolate trends from study data.
The Washington Post